Receptor activator of nuclear factor-B ligand (RANKL) and osteoprotegerin (OPG) represent the ligand and decoy receptor, respectively, of a pleiotropic cytokine system that regulates bone metabolism and vascular biology. 1 Elevated OPG serum levels have recently been shown to be associated with increased cardiovascular mortality in postmenopausal women. 2 In the September 3, 2002 issue of Circulation, Jono et al 3 reported increased OPG serum levels in 201 Japanese patients with coronary artery disease (CAD) and a positive correlation of OPG serum levels with the severity of CAD. In a cohort of 522 white men who underwent coronary angiography, we have confirmed that OPG serum levels are highest in those with advanced CAD, 4 indicating that these findings are independent of geographic and ethnic differences.
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We thank Drs Schoppet, Schaefer, and Hofbauer for their comments about our study of the association between serum osteoprotegerin (OPG) levels and the severity of coronary artery disease (CAD) 1 . They have confirmed that serum OPG levels are significantly greater in patients with advanced CAD than in those without CAD. Interestingly, they found that the serum levels of soluble receptor activator of nuclear factor-B ligand (RANKL) were significantly lower in patients with CAD than in those without CAD, and that serum soluble RANKL levels were correlated with serum OPG levels. In histological study, RANKL and OPG immunoreactivity was demonstrated in the nondiseased vessel wall and in the early atherosclerotic lesions in human tissues. 2 RANKL was present in the extracellular matrix surrounding the calcium mineral deposits of the plaques. Moreover, RANKL transcripts are detected in the calcified arteries of OPG deficient mice. 3 These findings suggest that RANKL may be involved in the regulation of mineralization in atherosclerotic lesions. The RANKL/OPG system may have an important role in the regulation of vascular disease. RANKL, OPG, and RANKLto-OPG ratio measurement in the serum may help to evaluate the activity of vascular disease.
